Navigation Links
A 300 Million Euro Boost for Biomedicine in Berlin
Date:11/13/2012

BERLIN, November 13, 2012 /PRNewswire/ --

Two of Berlin's largest biomedical research centers are merging to form the Berlin Institute of Health (BHI), a joint venture that will receive at least 300 million euros in new funding over the next five years. This makes Berlin an even more significant and attractive research site, not only in the field of biomedicine. This is happening at the right time, for an aging demographic means that there is an increasing demand for health care products and services. Germany Trade & Invest will have experts at this year's MEDICA, the world's largest health fair, from November 14 to 17 to inform visitors about the industry's latest business opportunities.

"The BHI will make Berlin one of the world's top sites for medical excellence and will attract the world's best scientists and junior doctors. The partnership between the Berlin state and federal government has created an exemplary model of cooperation between university and non-university research. Germany has a globally recognized biomedical sector, and it will only improve due to the Institute's innovative models to train medical talent," said Dr. Sandra Bütow, chemical and health expert at Germany Trade & Invest.

Germany is renowned for its effective public-private partnerships such as the Central Innovation Program SME, a country-wide support measure that provides sustainable support to the innovative capabilities and competiveness of small- and medium-sized enterprises. Participants include businesses and researchers from the health and wellness industry who collaborate in order to find innovative and value-added healthcare solutions.

General Electric has also seized on the market opportunity in Germany due to its infrastructure, research and development and changing demographic. Their objective is to powerfully expand its medical division and establish close partnerships with university hospitals.

Germany Trade & Invest
'/>"/>

SOURCE Germany Trade and Invest
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
2. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
3. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
4. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
5. Radius Closes $27.65 Million Second Tranche of Previously Announced Financing
6. BioPower Systems Awarded $5 Million from Victorian Government
7. InnoPharma Completes $15 Million Series A Financing
8. Aratana Therapeutics Completes $15 Million Series B Financing
9. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
10. CeNeRx BioPharma Completes $4.85 Million Financing
11. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... and Companies" to their offering. ... variations, development of sequencing technologies, and their applications. ... well as companies developing them. Various applications of ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... their offering. The markets for gene therapy ... approved gene therapy product and it is marketed in ... markets are estimated for the years 2014-2024. The estimates ...
(Date:9/2/2015)... 2, 2015  Neurotech Pharmaceuticals, Inc., announced today ... multicenter Phase 2 clinical trial of NT-503 Encapsulated ... recurrent subfoveal choroidal neovascularization secondary to age related ... vascular endothelial growth factor (VEGF) receptor protein continuously ... "This landmark proof-of-concept study will evaluate NT-503 ECT ...
(Date:9/2/2015)... September 2, 2015 BioLight ... or the "Company"), a firm that invests in, ... cancer diagnostics, announced today that presentations highlighting its ... be delivered at the Ophthalmology Futures European Forum ... of Cataract & Refractive Surgeons ("ESCRS"), both taking ...
Breaking Biology Technology:Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
... SHANGHAI, China, April 4, 2008 /Xinhua-PRNewswire-FirstCall/ -- WuXi,PharmaTech ... pharmaceutical,biotechnology and medical device research and development outsourcing,company ... today announced it,was awarded the 2007 Chemistry CRO ... Center of Emphasis (CoE)., (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ...
... FRANCISCO, Calif., and SINGAPORE, April 4, 2008 /PRNewswire/,-- ... on the,discovery and development of monoclonal antibody therapeutics ... today announced a,collaboration to advance the discovery of ... of the agreement, Raven will license its proprietary,whole ...
... Australia, April 3, 2008 /Xinhua-PRNewswire-FirstCall/ --,Pharmaxis Ltd (ASX: ... II,clinical trial in children with cystic fibrosis demonstrated ... Bronchitol that,matched that achieved by the current marketed ... months on Bronchitol reflects that,seen in a previous ...
Cached Biology Technology:WX Crowned 'Chemistry CRO of the Year' by Pfizer 2Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies 2Cystic Fibrosis Trial In Children Returns Positive Data 2Cystic Fibrosis Trial In Children Returns Positive Data 3Cystic Fibrosis Trial In Children Returns Positive Data 4
(Date:8/5/2015)... 2015 The biosensors market is proving highly ... into newer sectors, and development of devices resulting in ... has seen the entry of multiple participants each year ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... the Global Biosensors Market ( http://www.frost.com/nee9 ), finds ...
(Date:8/4/2015)... 4, 2015  AMRI (NASDAQ: AMRI ) today reported financial ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 ... including a $0.05 decrease in EPS from royalties in the current ... "We are very pleased to present another strong ...
(Date:7/31/2015)... Kina, 31. juli 2015 Den 10. internationale ... af BGI fra den 22. - 25. oktober i ... fejrer sin 10-års fødselsdag i år. Siden starten i ... årlige møder på ,omik,-feltet, og er en af de ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... important component of early genetic material which has been found ... published on 15 June 2008. The finding suggests that ... of DNA and RNA may have come from the stars. ... that their research, published in the journal Earth and ...
... D.C. A synthetic chemical based on a compound ... of human tumors in laboratory studies, and should be ... researchers at Georgetown University Medical Center. , "We have ... this study suggests one reason why that might be ...
... ALAMOS, New Mexico, June 12, 2008Less than a ... began operating at world-record petaflop/s data-processing speeds, Los ... mimic extremely complex neurological processes. Welcome to ... science at the petascale. The prefix "peta" ...
Cached Biology News:Scientists confirm that parts of earliest genetic material may have come from the stars 2Synthetic cocoa chemical slows growth of tumors in human cell lines 2Roadrunner supercomputer puts research at a new scale 2Roadrunner supercomputer puts research at a new scale 3
...
...
D.R. Harper and C. Grose (1994) • Includes: virus structure & replication, fundamental virology, immunology and pathogenesis, vaccines and antiviral drugs, novel diagnostic techniques, cloning a...
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
Biology Products: